Thu, 31 July 2014
Dr. Nasser Hanna outlines the possible benefits of consolidation chest radiation for small cell lung cancer patients who respond well to chemotherapy.
Direct download: GRACEcast-254_Lung-Video_ASCO_2014_Consolidation_Radiation_SCLC.mp4
Category:Lung-Cancer-Video -- posted at: 12:00pm PDT |
Tue, 29 July 2014
What puts you at risk for inherited kidney cancer? Dr. Nizar Tannir discusses the signs doctors look for to determine if a kidney cancer patient should be screened for a familial syndrome.
Direct download: GRACEcast-253_Kidney-Video_ASCO_2014_Rare_Kidney_Tumor_Management.mp4
Category:Kidney-Cancer-Video -- posted at: 12:00pm PDT |
Sun, 27 July 2014
The doctors discuss the circumstances under which small cell lung cancer patients should receive prophylactic cranial irradiation.
Direct download: GRACEcast-252_Lung-Video_ASCO_2014_Prophylactic_Cranial_Irradiation_SCLC.mp4
Category:Lung-Cancer-Video -- posted at: 12:00pm PDT |
Thu, 24 July 2014
NanoString Technology may help doctors learn what is driving tumor growth in kidney cancer patients and, therefore, determine what treatments may be most effective for them.
Direct download: GRACEcast-251_Kidney-Video_ASCO_2014_RCC_NanoString_Treatment.mp4
Category:Kidney-Cancer-Video -- posted at: 12:00pm PDT |
Tue, 22 July 2014
Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lung cancer. Though it achieved a statistical increase in OS, he does not consider it clinically relevant.
Direct download: GRACEcast-250_Lung-Video_ASCO_2014_Necitumumab_Squamous_LC.mp4
Category:Lung-Cancer-Video -- posted at: 12:00pm PDT |
Sun, 20 July 2014
Dr. Daniel Heng is the namesake of the Heng Criteria, which evaluates various factors of kidney cancer patients to determine their prognoses.
Direct download: GRACEcast-249_Kidney-Video_ASCO_2014_Kidney_Cancer_Heng_Criteria.mp4
Category:Kidney-Cancer-Video -- posted at: 12:00pm PDT |
Thu, 17 July 2014
The REVEL trial studied 1,200 non-small cell lung cancer patients to see if the drug Cyramza (ramucirumab) improved overall surival. The doctors had mixed feelings about the results.
Direct download: GRACEcast-248_Lung-Video_ASCO_2014_Cyramza_Second_Line_Treatment.mp4
Category:Lung-Cancer-Video -- posted at: 12:00pm PDT |
Tue, 15 July 2014
Dr. Lauren Harshman explains what PD1 (an immune T-cell) and PDL1 (a protein on the PD1 T-cell) are and how new drugs impact them to fight kidney cancer.
Direct download: GRACEcast-247_Kidney-Video_ASCO_2014_PD1_PDL1_Kidney_Explained.mp4
Category:Kidney-Cancer-Video -- posted at: 12:00pm PDT |
Sun, 13 July 2014
The doctors discuss the new FDA-approved drug for ALK positive lung cancer patients, Zykadia (ceritinib), including the dosage level, potential side effects and the ability of Zykadia to impact brain metastases.
Direct download: GRACEcast-246_Lung-Video_ASCO_2014_ALK_Positive_New_Hope_Zykadia.mp4
Category:Lung-Cancer-Video -- posted at: 12:00pm PDT |
Thu, 10 July 2014
Drugs in early stage clinical trials seem to show benefit for non-clear cell kidney cancer, but more trials must take place and patients are desperately needed to enroll in them.
Direct download: GRACEcast-245_Kidney-Video_ASCO_2014_No_Answer_Non-Clear_Cell_Kidney.mp4
Category:Kidney-Cancer-Video -- posted at: 12:00pm PDT |